Global In Vitro Diagnostics Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
TEG/Thrombelastrography TEG/Thrombelastrography and ROTEM/Rotational Thromboelastrometry and |
Upcoming |
|
|
ROTEM/Rotational Thromboelastrometry ROTEM/Rotational Thromboelastrometry and TEG/Thrombelastrography and |
Upcoming |
|
|
Sonoclot Sonoclot and TEG/Thrombelastrography and |
Upcoming |
|
|
North American Clinical Chemistry The North American clinical chemistry market was estimated at $3,852.7 million in 2013 and is expected to reach $5,370.5 million by 2019, at a CAGR of 7.2% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
European Clinical Chemistry Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Europe Coagulation Europe holds the second position in the global coagulation market after the Americas. Germany commanded the largest share (20%) at an estimated $186.9 million in 2013 and is expected to reach $231.1 million by 2018, at a CAGR of 4.5% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Upcoming |
|
|
Asia-Pacific Clinical Chemistry Analyzer The Asia-Pacific clinical chemistry market is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1047.2 million by 2018, at a CAGR of 16.0% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report. |
Mar 2015 |
|
|
Europe Reagents & Kits The major changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The report “European IVD Reagents & Kits Market forecast for 2018 “analyzes the market by 2 segments such as general purpose Reagents & Kits and analyte specific Reagents & Kits. |
Upcoming |
|
|
Europe Instruments The major changes in this sector have been brought about as a result of the convergence of system engineering, automation, and IT technology. Thus, the new technologies have enabled a better understanding of disease processes. The report “European IVD Instruments Market forecast for 2018 “analyzes the market by 3 segments such as high risk and risk devices, devices for self testing and other devices. |
Upcoming |
|
|
North American Tissue Diagnostics The North American Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, value was estimated to be $1,228.14 million in 2013 and is expected to be $1,684.24 million by 2018, at a CAGR of 6.52% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.). |
Upcoming |
|
|
European Tissue Diagnostics Market The European Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, which was valued $868.49 million in 2013 and is expected to be $1136.70 million by 2018, at a CAGR of 5.53% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.). |
Upcoming |
|
|
BRIC Tissue Diagnostics The BRIC Tissue Diagnosis Devices Market, mainly driven by rapidly increasing incidence of cancer, which was valued $264.75 million in 2013 and is expected to be $476.88 million by 2018, at a CAGR of 12.49% from 2013 to 2018. The market divided by 4 segments such as Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining are the technology segments of the tissue diagnostics market. The major players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology, Inc. (U.S.), and Bio SB (U.S.). |
Upcoming |
|
|
Europe Hematology Europe holds second largest market position after North America. Germany commanded the largest share 20% of the Europe hematology market at an estimated $272.8 million in 2013 and is expected to reach $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The report “European Hematology Market forecast for 2018 “analyzes the market by 2 segments such as hematology reagents and hematology instruments. |
Upcoming |
|
|
North America Hematology North America commanded the largest share 41.75% of the Global hematology market at an estimated $1810.4 million in 2013 and are expected to reach $2479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments. |
Upcoming |
|
|
Asia Hematology Asian Hematology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of Asian hematology market at an estimated $216.0 million in 2013 and is expected to reach $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018. The report “Asian Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments. |
Upcoming |
|
|
North America Coagulation The Americas commanded the largest share 42% of the Global Coagulation market at an estimated $1240.8 million in 2013 and are expected to reach $1638.7 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Coagulation Market forecast for 2018 “analyzes the market by two segments such as coagulation instruments and coagulation reagents. |
Upcoming |
|
|
Asia Coagulation Asian Coagulation market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $148.0 million in 2013 and is expected to reach $283.6 million by 2018, at a CAGR of 14.6% from 2013 to 2018. The report “Asian Coagulation Market forecast for 2018 “analyzes the market by two segments such as coagulation instruments and coagulation reagents. |
Upcoming |
|
|
Europe Immunoassay Europe holds second largest market position in Global Immunoassay Market. Germany commanded the largest share 20% of the European immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The report “European Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments. |
Upcoming |
|
|
Europe Microbiology Next to America, Europe holds second largest market position. Germany commanded the largest share 20% at an estimated $223.7 million in 2013 and is expected to reach $272.5 million by 2018, at a CAGR of 4.2% from 2013 to 2018. The report “European Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents. |
Upcoming |
|
|
North America Immunoassay The Americas commanded the largest share 42% of the Global Immunoassay market at an estimated $5248.2 million in 2013 and are expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. The report “North American Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments. |
Upcoming |
In Vitro Diagnostics
